SCHEMBL16193397

SCHEMBL16193397

NCc1ccc2c(c1)CN(C(CCC=O)C(N)=O)C2=O

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SDCBP O00560 6/20 0.35
▸ SDC2 P34741 6/20 0.35
▸ THRB P10828 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ITGB3 P05106 1/20 0.33
▸ ITGA2B P08514 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23482963 0.87 MAPT (0.39) ALOX15MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL24291608 0.86 ALOX15 (0.40) ALOX15MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL24289719 0.86 ALOX15 (0.40) ALOX15MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL25075338 0.85 SDCBP (0.45) ALOX15MAPTSMN1; SMN2KDM4ESDCBP
SCHEMBL12942069 0.82 ALOX15 (0.54) ALOX15MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL15128633 0.81 ERCC1 (0.42) MAPTNPC1RAB9ASDCBPSDC2
SCHEMBL24288862 0.79 KDM4E (0.42) ALOX15MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL21983039 0.79 ITGB3 (0.39) ALOX15MAPTSMN1; SMN2KDM4EITGB3
SCHEMBL21480827 0.79 ITGB3 (0.39) ALOX15MAPTSMN1; SMN2KDM4EITGB3
SCHEMBL24288936 0.79 ALDH1A1 (0.45) KDM4EMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023280237-A1 SYNTHESIS AND APPLICATION OF PHOSPHATASE DEGRADER 海创药业股份有限公司 2023-01-12 — — WO disclosed
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 — — WO disclosed
WO-2014172429-A1 COMBINATION THERAPY COMPRISING A TOR KINASE INHIBITOR AND AN IMID COMPOUND FOR TREATING CANCER SIGNAL PHARMACEUTICALS, LLC (US) 2014-10-23 — — WO disclosed
Send feedback